Nestle SA said it would be delivering baby formula to the United States from its plants in Switzerland and the Netherlands to help ease up the shortage in U.S. markets. The company announced on Tuesday, May 17, that it will supply Alfamino and Gerber baby formula brands to America.
As per Reuters, parents are panicking as they can no longer find any infant milk formulas in supermarkets as the shelves are always empty these days. The shortage started when Abbott Laboratories, a leading medical devices and health care company in the U.S., recalled several types of its popular baby formula brands, including Similac, EleCare, and Alimnetum.
The milk formula manufacturer issued a recall on the said brands in February following the deaths of two infants who contracted a rare kind of infection. The U.S. Food and Drug Administration (USFDA) carried out an investigation on Abbott and discovered traces of the pathogen Cronobacter sakazakii in its plant in Michigan.
Abbott explained that the said pathogen may have been found in environmental testing during the investigation, but it has not been linked to any infant illness. It also stated that no distributed product was ever tested positive for the presence of any bacteria such as Salmonella Newport and Cronobacter sakasakii, based on the tests. But still, the company still issued the recall due to the complaints it received.
"While Abbott's testing of finished product detected no pathogens, we are taking action by recalling the powder formula manufactured in this facility with an expiration of April 1, 2022, or later," Abbott stated in a press release at that time. "No Abbott liquid formulas, powder formulas, or nutrition products from other facilities are impacted by the recall."
As this incident led to the formula shortage, Nestle will help alleviate the problem by bringing its infant milk formula products to the U.S. the company will be rushing the deliveries as the shortage has now reached the nationwide level.
"We prioritized these products because they serve a critical medical purpose as they are for babies with cow's milk protein allergies," Nestle stated. "Both products (Alfamino and Gerber) were already being imported but we moved shipments up and rushed via air to help fill immediate needs."
Meanwhile, Reckitt Benckiser is also increasing its production of infant formula by 30% to help combat the shortage. It has also upped the frequency of its deliveries to stores and groceries in the U.S.


Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
South Korea Factory Activity Returns to Growth in December on Export Rebound
U.S. Stock Futures Slip as Year-End Trading Turns Cautious
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit
Asian Currencies Trade Flat as Dollar Weakens in Thin New Year Trading
U.S. Stock Index Futures Steady as Markets Await Fed Policy Clues in Holiday-Thinned Trade
Forex Markets Hold Steady as Traders Await Fed Minutes Amid Thin Year-End Volumes
Japanese Business Leaders Urge Government Action as Weak Yen Strains Economy
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
China Imposes 55% Tariff on Beef Imports Above Quota to Protect Domestic Industry
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle
Federal Reserve Begins Treasury Bill Purchases to Stabilize Reserves and Money Markets
South Korea Exports Hit Record High as Global Trade Momentum Builds
Citi Forecasts a Volatile but Ongoing Bull Market for S&P 500 in 2026
Asian Markets End Year on AI Optimism as Precious Metals and Currencies Shine 



